UK Companies House feature
TYMPA HEALTH TECHNOLOGIES LIMITED
Cash
£1M
+78.8% vs 2022
Net assets
£7M
+52.7% vs 2022
Employees
79
+88.1% vs 2022
Profit before tax
—
Period ending 2023-12-31
Profile
- Company number
- 11029091
- Status
- Active
- Incorporation
- 2017-10-24
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Net assets
8-year trend · vs UK Healthcare median
Accounts
8-year trend · latest 2023-12-31
| Metric | Trend | 2019-12-31 | 2020-01-01 | 2020-12-31 | 2021-01-01 | 2021-12-31 | 2022-01-01 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | — | — | — | |
| Net profit | — | — | — | — | — | — | — | — | |
| Cash | £1,176,840 | — | £904,259 | — | £4,579,080 | — | £754,750 | £1,349,386 | |
| Total assets less current liabilities | £2,247,712 | — | £2,440,335 | — | £6,317,910 | — | £4,954,680 | £7,520,908 | |
| Net assets | £2,247,712 | — | £2,350,524 | — | £6,247,910 | — | £4,904,680 | £7,490,908 | |
| Equity | £2,247,712 | — | £2,350,524 | — | £6,247,910 | — | £4,904,680 | £7,490,908 | |
| Average employees | 2 | — | 2 | — | 7 | — | 42 | 79 | |
| Wages | — | — | — | — | — | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Kreston Reeves Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Despite the Group making a loss for the year of £7,601,958 (2023: restated £12,129,184), the Group is in a net current asset position of £7,315,151 (2023: restated £1,831,590) and a net asset position of £10,709,411 (2023: restated £6,411,885) and therefore the financial statements have been prepared on a going concern basis. The Group confirmed their cash and marketable securities will satisfy the projected working capital and capital expenditure requirements for the Group for at least the next 12 months. Liquidity and capital expenditure requirements are continuously reviewed by the Group. On this basis, the Directors have concluded the Group has adequate resources to continue in operation existence for the foreseeable future.”
Subsidiaries
- Tympa Health Technologies Inc · 100% held · Miami, Florida
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2025-01-06 | — | — |
| CROSS DICKENS, Daniel | Director | 2024-11-12 | Jul 1979 | British |
| RAMDOO, Savram Krishan, Dr | Director | 2017-10-24 | Apr 1985 | British |
| SUTTON, Nicholas Robert Arnott | Director | 2024-12-02 | May 1964 | British |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| RAMDOO, Savram Krishan, Dr | Secretary | 2017-10-24 | 2025-01-06 |
| AJMANI, Karin | Director | 2022-03-01 | 2024-11-12 |
| CASHMAN, Steve | Director | 2023-12-19 | 2024-10-23 |
| DESAI, Arjun Mukund | Director | 2021-10-11 | 2024-11-12 |
| MCCORMICK, Stephen Ross | Director | 2018-05-21 | 2019-04-04 |
| PATEL, Manish Kumar | Director | 2017-10-24 | 2018-05-21 |
| POOLE, Mark Nicholas John | Director | 2019-04-04 | 2024-07-25 |
| PRIOR, David Gifford Leathes, Lord | Director | 2022-05-01 | 2024-11-12 |
| STRINGER, Richard Joseph | Director | 2023-02-10 | 2023-10-06 |
| TATLA, Taranjit Singh | Director | 2017-10-24 | 2018-05-21 |
| VALLIN, Matthieu | Director | 2023-07-06 | 2024-11-12 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Mark Nicholas John Poole | Individual | Shares 25–50%, Voting 25–50% | 2025-07-21 | Active |
| Mr Mark Nicholas John Poole | Individual | Shares 25–50% | 2019-03-04 | Ceased 2023-02-16 |
| Ceek Health Ebt Limited | Corporate entity | Shares 25–50% | 2018-05-21 | Ceased 2019-02-28 |
| Mr Savram Krishan Ramdoo | Individual | Significant influence | 2018-05-21 | Ceased 2018-05-21 |
| Mr Savram Krishan Ramdoo | Individual | Shares 25–50%, Voting 25–50% | 2017-10-24 | Ceased 2018-05-21 |
| Mr Taranjit Singh Tatla | Individual | Shares 25–50%, Voting 25–50% | 2017-10-24 | Ceased 2018-05-21 |
Filing timeline
Last 20 of 103 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-31 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2026-01-16 | CS01 | confirmation-statement | confirmation statement with updates |
| 2026-01-16 | PSC01 | persons-with-significant-control | notification of a person with significant control |
| 2026-01-16 | PSC09 | persons-with-significant-control | withdrawal of a person with significant control statement |
| 2025-11-11 | AA | accounts | accounts with accounts type group |
| 2025-11-05 | SH01 | capital | capital allotment shares |
| 2025-10-31 | RESOLUTIONS | resolution | resolution |
| 2025-10-31 | MA | incorporation | memorandum articles |
| 2025-01-09 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-01-07 | TM02 | officers | termination secretary company with name termination date |
| 2025-01-07 | AP04 | officers | appoint corporate secretary company with name date |
| 2024-12-10 | AP01 | officers | appoint person director company with name date |
| 2024-12-10 | SH10 | capital | capital variation of rights attached to shares |
| 2024-12-10 | SH08 | capital | capital name of class of shares |
| 2024-12-10 | SH08 | capital | capital name of class of shares |
| 2024-12-10 | SH10 | capital | capital variation of rights attached to shares |
| 2024-12-09 | SH01 | capital | capital allotment shares |
| 2024-12-09 | SH01 | capital | capital allotment shares |
| 2024-12-09 | SH01 | capital | capital allotment shares |
| 2024-11-27 | MA | incorporation | memorandum articles |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory